Restasis is specifically designed to help increase tear production in people who have dry eyes caused by eye inflammation. When the eyes become inflamed, it can interfere with the eyes' ability to produce tears. As a type of immunosuppressant, Restasis works to decrease eye inflammation by decreasing the activity of the immune system.
Although many people do not have any problems while using this eye medication, Restasis can cause side effects, such as eye redness, burning, and itching. If negative reactions do occur, they tend to be mild and easily treated.
(Click Restasis for more information on what this eye medication is used for and how it works. This article also provides details on additional side effects and some safety precautions to be aware of before beginning treatment.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Micromedex Healthcare Series [Internet database]. Greenwood Village, Colo: Thomson Reuters (Healthcare), Inc. Updated periodically. Accessed August 4, 2009.
National Library of Medicine (US). Hazardous Substances Data Bank (HSDB). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB. Accessed August 4, 2010.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.
National Library of Medicine (US). Drugs and Lactation Database (LactMED). NLM Web site. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT. Accessed April 21, 2010.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed August 3, 2010.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click